Fatal Rhabdomyolysis in a Patient with Liver Cirrhosis after Switching from Simvastatin to Fluvastatin

HMG-CoA reductase inhibitors (statins) are widely used to treat hypercholesterolemia. Among the adverse effects associated with these drugs are statin-associated myopathies, ranging from asymptomatic elevation of serum creatine kinase to fatal rhabdomyolysis. Fluvastatin-induced fatal rhabdomyolysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Baek, Seung Don, Jang, Sun-Joo, Park, So-Eun, Ok, Tae Jin, Leem, Jaechan, Lee, Ho-Su, Park, So Jung, Kim, Tae Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230026/
https://www.ncbi.nlm.nih.gov/pubmed/22148003
http://dx.doi.org/10.3346/jkms.2011.26.12.1634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230026/
https://www.ncbi.nlm.nih.gov/pubmed/22148003
http://dx.doi.org/10.3346/jkms.2011.26.12.1634

Ejemplares similares